Related Experiment Video
Updated: Feb 7, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
MSI2 knockdown represses extrahepatic cholangiocarcinoma growth and invasion by inhibiting epithelial-mesenchymal
Feihu Hu1,2, Chenhai Liu1,2, Fang Xie1,2
1Department of General Surgery, Anhui Provincial Hospital Affiliated to Anhui Medical University, Hefei, China, 198538838@qq.com.
Purpose:
To investigate the expression and functional role of Musashi2 (MSI2), an RNA-binding protein, in extrahepatic cholangiocarcinoma (eCCA).
Patients And Methods:
We measured MSI2 expression in human specimens and cell lines using Western blot and quantitative real-time polymerase chain reaction, and we analyzed its association with clinicopathologic features in eCCA patients. Univariate and multivariate analyses were performed to identify risk factors correlated with overall survival and disease-free survival. Functional experiments were used to study the mechanisms of MSI2 in regulating eCCA cell growth, migration, and invasion.
Results:
MSI2 expression was upregulated significantly in both human specimens and cell lines, and high MSI2 expression was associated with lymph node metastasis, advanced TNM stage, and poor prognosis in eCCA patients. Additionally, MSI2 overexpression promoted eCCA cell growth, migration, and invasion, while MSI2 knockdown repressed eCCA cell migration and invasion by inhibiting epithelial-mesenchymal transition.
Conclusion:
MSI2 is an independent prognostic factor for eCCA patients, and MSI2 downregulation inhibits eCCA cell growth and metastasis. MSI2 may be a potential therapeutic target for eCCA patients.
Insights
Musashi2 (MSI2) is upregulated in extrahepatic cholangiocarcinoma (eCCA), promoting tumor growth and metastasis. MSI2 is a potential therapeutic target for eCCA patients, as its inhibition hinders cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Extrahepatic cholangiocarcinoma (eCCA) is a rare and aggressive biliary tract cancer.
- The molecular mechanisms driving eCCA progression remain incompletely understood.
- Identifying novel therapeutic targets is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the expression and functional role of Musashi2 (MSI2) in eCCA.
- To determine if MSI2 serves as a prognostic marker in eCCA.
- To elucidate the mechanisms by which MSI2 influences eCCA cell behavior.
Main Methods:
- MSI2 expression analysis in human eCCA specimens and cell lines via Western blot and qPCR.
- Correlation analysis between MSI2 expression and clinicopathologic features.
- Functional studies assessing the impact of MSI2 modulation on eCCA cell growth, migration, and invasion.
Main Results:
- MSI2 expression was significantly upregulated in eCCA tissues and cell lines.
- High MSI2 expression correlated with lymph node metastasis, advanced TNM stage, and poor prognosis.
- MSI2 overexpression enhanced eCCA cell proliferation, migration, and invasion; MSI2 knockdown inhibited these processes by suppressing epithelial-mesenchymal transition.
Conclusions:
- MSI2 is an independent prognostic factor for eCCA.
- Downregulation of MSI2 inhibits eCCA cell growth and metastasis.
- MSI2 represents a promising therapeutic target for eCCA treatment.
Related Concept Videos
Phase Transitions
Repressed Memory
Feedback Inhibition
Properties of Transition Metals
Cooperative Allosteric Transitions
Phase Transitions: Vaporization and Condensation

